Characterization of human milk lipids with bioactive potential and the impact of maternal diabetes mellitus on their compositio
- Conditions
- O24.4E10E66U07.1Diabetes mellitus arising in pregnancyType 1 diabetes mellitusObesityCOVID-19, virus identified
- Registration Number
- DRKS00027910
- Lead Sponsor
- Dr. von Haunersches Kinderspital, Abteilung Stoffwechsel und Ernährung
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 110
Healthy women and women with a history of GDM or of pre-existing Type 1 Diabetes
- Singleton pregnancy
- Reported pre pregnancy BMI: 18 - 35 kg/m2
- No serious medical disorder that is expected to affect lactation or metabolism
- Omnivorous or vegetarian diet
- Intention to fully breastfeed the infant for at least 4 month
- Maternal vegan or ketogenic-diet
- Maternal hypertension (with medication) or severe pre-eclampsia
- Chronic diseases assumed to affect maternal or infant metabolism or infant growth (other than Type 1 Diabetes), e.g. maternal Diabetes mellitus Type 2
- Severe pregnancy complications like severe pre-eclampsia or gestosis
- Pre-term delivery (< 37th gestational week)
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Characterization of human milk lipids and metabolites that may have a bioactive effect on infant development considering a variety of potential influencing factors, including maternal gestational diabetes and type 1 diabetes.
- Secondary Outcome Measures
Name Time Method -To investigate the impact of stage of lactation and other maternal characteristics, such as maternal diet and lifestyle factors, BMI, Covid-19 infection and genotype, on human milk metabolome and lipidome. <br>-To characterize the association of human milk metabolome and lipidome with maternal and infant metabolism.<br>-To characterize associations of human milk metabolome and lipidome with infant growth measures.